Carlos Alonso-Moreno

32PUBLICATIONS
62CO-AUTHORS
Molecular targetsGlycoconjugatesNanofabrication, growth and self assemblyPharmaceutical delivery technologiesPolymers and plastics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 12, 2026
Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma.

|Apr 22, 2026
Guanidine-Based Ligands in Bioinorganic Chemistry: Coordination Modes and Applications in Anticancer Metallodrugs.

|Apr 09, 2026
Rational design of lipid-based nanoparticles for targeted anticancer therapies.

María Arenas-Moreira, Alberto Ocaña, Carlos Alonso-Moreno

|Apr 06, 2026
Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.

Alberto Moreno-Fernández, Elena Domínguez-Jurado, Marc Martínez de Sarasa Buchaca

|Dec 01, 2025
Understanding the Chemical Characteristics of Payloads and the Expression of Tumor-Associated Antigens of ADCs in Clinical Development.

Cristina Nieto-Jiménez, Lucía Paniagua-Herranz, Carlo Bosi

|Feb 26, 2025
Understanding the Toxicity Profile of Approved ADCs.

Pablo Ballestín, Alfonso López de Sá, Cristina Díaz-Tejeiro

Pageof 6

Frequent Collaborators

20 joint publications

Iván Bravo

9 joint publications

José Antonio Castro-Osma

9 joint publications

Alberto Ocaña

9 joint publications

Agustín Lara-Sanchez